Related Experiment Video
Updated: Jul 26, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Downmodulation of bFGF-binding protein expression following restoration of p53 function
Z A Sherif1, S Nakai, K F Pirollo
1Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, USA.
Abstract:
Angiogenesis is a requirement for solid tumor growth. Therefore, inhibition of this neovascularization is one mechanism by which restoration of wtp53 function may lead to tumor regression. Here we report that adenoviral vector-mediated wild-type p53 transduction results in growth inhibition of squamous cell carcinoma of the head and neck tumor cells both in vitro and in a xenograft mouse model. This growth inhibition is associated with the down-regulation of the expression of fibroblast growth factor binding protein, a secreted protein required for the activation of angiogenic factor basic FGF. These findings suggest that wtp53-induced tumor regression is due, at least in part, to antiangiogenesis mediated by the downmodulation of fibroblast growth factor binding protein.
Insights
Restoring wild-type p53 function inhibits head and neck squamous cell carcinoma growth. This tumor regression is linked to reduced angiogenesis via down-regulation of fibroblast growth factor binding protein.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Solid tumor growth relies on angiogenesis (new blood vessel formation).
- Inhibiting tumor neovascularization is a strategy for tumor regression.
- Restoring wild-type p53 (wtp53) function may impede tumor growth through anti-angiogenic mechanisms.
Purpose of the Study:
- To investigate the effect of wild-type p53 restoration on head and neck squamous cell carcinoma (HNSCC) growth.
- To determine the role of wtp53 in regulating angiogenesis in HNSCC.
- To identify molecular targets mediating wtp53-induced anti-tumor effects.
Main Methods:
- Adenoviral vector-mediated delivery of wtp53 into HNSCC cells.
- In vitro cell culture experiments to assess tumor cell growth.
- In vivo xenograft mouse models to evaluate tumor growth inhibition.
- Analysis of fibroblast growth factor binding protein (FGF-BP) expression levels.
Main Results:
- Adenoviral wtp53 transduction significantly inhibited HNSCC cell growth both in vitro and in vivo.
- Tumor growth inhibition was associated with decreased expression of FGF-BP.
- FGF-BP down-regulation correlated with reduced activation of basic FGF, an angiogenic factor.
Conclusions:
- Restoration of wtp53 function can inhibit HNSCC tumor growth.
- wtp53-induced tumor regression is, in part, mediated by anti-angiogenesis.
- Down-modulation of FGF-BP is a key mechanism in wtp53-driven anti-angiogenic effects.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
TGF - β Signaling Pathway

